Skip to Main Content

Paper Details

Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07.
Thorac Cancer
13
2020
Author NameAffiliation
Bhumsuk KeamSeoul National University Hospital, Seoul National University College of Medicine
Bhumsuk KeamCancer Research Institute, Seoul National University College of Medicine
Jin-Soo KimSeoul National University Boramae Medical Center
Jong-Il KimCancer Research Institute, Seoul National University College of Medicine
Jong-Il KimGenomic Medicine Institute, Medical Research Center, Seoul National University
Jong-Il KimSeoul National University Graduate School
  • 1 - 6

Datasets